Insider · CIK 0001678984

Schilke Tobin

CIK 0001678984 Name as filed on the most recent filing

Filed as Schilke Tobin (17)

20 transaction lines · from 17 filings · filed 2017-01-30 to 2026-03-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

20 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-03-03 S, Open-market sale Crinetics Pharmaceuticals, Inc.CRNX 266,305, disposed Open Form 4 filing 0001628280-26-014772
2024-03-18 S, Open-market sale Revance Therapeutics, Inc.RVNC 47,204, disposed Open Form 4 filing 0001479290-24-000066
2023-07-03 S, Open-market sale Revance Therapeutics, Inc.RVNC 42,593, disposed Open Form 4 filing 0001479290-23-000083
2023-06-02 S, Open-market sale Revance Therapeutics, Inc.RVNC 15,500, disposed Open Form 4 filing 0001479290-23-000077
2023-06-01 S, Open-market sale Revance Therapeutics, Inc.RVNC 82,570, disposed Open Form 4 filing 0001479290-23-000077
2023-05-15 S, Open-market sale Revance Therapeutics, Inc.RVNC 739,338, disposed Open Form 4 filing 0001479290-23-000075
2023-05-01 S, Open-market sale Revance Therapeutics, Inc.RVNC 101,472, disposed Open Form 4 filing 0001479290-23-000056
2023-04-03 S, Open-market sale Revance Therapeutics, Inc.RVNC 102,912, disposed Open Form 4 filing 0001479290-23-000053
2023-03-09 S, Open-market sale Revance Therapeutics, Inc.RVNC 584,884, disposed Open Form 4 filing 0001479290-23-000036
2023-03-01 S, Open-market sale Revance Therapeutics, Inc.RVNC 107,234, disposed Open Form 4 filing 0001479290-23-000031
2023-02-01 S, Open-market sale Revance Therapeutics, Inc.RVNC 110,755, disposed Open Form 4 filing 0001479290-23-000015
2023-01-20 S, Open-market sale Revance Therapeutics, Inc.RVNC 31,000, disposed Open Form 4 filing 0001479290-23-000012
2023-01-09 S, Open-market sale Revance Therapeutics, Inc.RVNC 3 lines 100,525, disposed Open Form 4 filing 0001479290-23-000007
2018-06-26 S, Open-market sale Achaogen IncAKAO 2,858, disposed Open Form 4 filing 0001140361-18-030425
2018-06-11 S, Open-market sale Achaogen IncAKAO 24,940, disposed Open Form 4 filing 0001140361-18-028440
2018-02-21 S, Open-market sale Achaogen IncAKAO 11,822, disposed Open Form 4 filing 0001140361-18-009970
2017-06-12 S, Open-market sale Achaogen IncAKAO 44,481, disposed Open Form 4 filing 0001140361-17-025045
2017-01-26 S, Open-market sale Achaogen IncAKAO 16,025, disposed Open Form 4 filing 0001140361-17-003552

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 20
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Schilke Tobin, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001678984

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.